Clinical trials
Metabolic Diseases trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2024 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 4 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Kastle Therapeutics, LLC | 2 |
| University of Sao Paulo | 2 |
| University of Sao Paulo General Hospital | 2 |
| 89bio, Inc. | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| BiomeHub Biotechnology Company | 1 |
| Federal University of Minas Gerais | 1 |
| Federal University of Rio Grande do Sul | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 25 |
| Diabetes Mellitus | 9 |
| Diabetes Mellitus, Type 2 | 9 |
| Glucose Metabolism Disorders | 9 |
| Endocrine System Diseases | 7 |
| Genetic Diseases, Inborn | 5 |
| Lipid Metabolism Disorders | 5 |
| Metabolism, Inborn Errors | 5 |
| Hyperlipidemias | 3 |
| Infant, Newborn, Diseases | 3 |
Trials
Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.